CY161A - Improvements in or relating to a process for the production of crystalline insulin - Google Patents

Improvements in or relating to a process for the production of crystalline insulin

Info

Publication number
CY161A
CY161A CY16157A CY16157A CY161A CY 161 A CY161 A CY 161A CY 16157 A CY16157 A CY 16157A CY 16157 A CY16157 A CY 16157A CY 161 A CY161 A CY 161A
Authority
CY
Cyprus
Prior art keywords
relating
production
crystalline insulin
insulin
crystalline
Prior art date
Application number
CY16157A
Other languages
English (en)
Original Assignee
Novo Terapeutisk Labor As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Terapeutisk Labor As filed Critical Novo Terapeutisk Labor As
Publication of CY161A publication Critical patent/CY161A/xx

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D9/00Crystallisation
    • B01D9/005Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • C07K14/625Extraction from natural sources
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
CY16157A 1952-06-23 1957-06-26 Improvements in or relating to a process for the production of crystalline insulin CY161A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK198252AA DK78069C (da) 1952-06-23 1952-06-23 Fremgangsmåde til fremstilling af krystallinsk insulin.

Publications (1)

Publication Number Publication Date
CY161A true CY161A (en) 1957-06-26

Family

ID=8141106

Family Applications (1)

Application Number Title Priority Date Filing Date
CY16157A CY161A (en) 1952-06-23 1957-06-26 Improvements in or relating to a process for the production of crystalline insulin

Country Status (6)

Country Link
US (1) US2920014A (de)
CY (1) CY161A (de)
DE (1) DE962637C (de)
DK (1) DK78069C (de)
FR (1) FR1167005A (de)
GB (1) GB733740A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3327709A1 (de) * 1983-07-29 1985-02-07 Hoechst Ag, 6230 Frankfurt Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung
DE3327928A1 (de) * 1983-08-03 1985-02-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production
US5504188A (en) * 1994-06-16 1996-04-02 Eli Lilly And Company Preparation of stable zinc insulin analog crystals
US5597893A (en) * 1994-10-31 1997-01-28 Eli Lilly And Company Preparation of stable insulin analog crystals
AR002976A1 (es) * 1995-03-31 1998-05-27 Lilly Co Eli Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
CA2910494C (en) 2004-07-19 2018-10-23 Biocon Limited Insulin-oligomer conjugates, formulations and uses thereof
MX2010003979A (es) * 2007-10-16 2010-06-02 Biocon Ltd Composicion farmaceutica oralmente administrable y proceso para su preparacion.
GB201409451D0 (en) 2014-05-28 2014-07-09 Ipabc Ltd Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms
WO2016032869A1 (en) 2014-08-26 2016-03-03 Merck Sharp & Dohme Corp. Method for preparing crystalline insulin or insulin analog compositions
AU2018341109B2 (en) * 2017-09-26 2022-02-17 Biocon Biologics India Limited Integrated automated filtration for separation, washing and drying of peptide crystals

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2143590A (en) * 1936-09-26 1939-01-10 Univ Alberta Insulin preparation and process of producing crystals of insulin
US2143591A (en) * 1936-09-26 1939-01-10 Univ Alberta Therapeutic preparation and process of making and using it
DE835499C (de) * 1945-05-17 1952-03-31 Novo Terapeutisk Labor As Verfahren zur Herstellung von Inselhormon in kristallinischer Form
US2626228A (en) * 1945-05-17 1953-01-20 Novo Terapeutisk Labor As Method of producing crystalline insulin
US2779706A (en) * 1950-08-12 1957-01-29 Organon Insulin extraction
US2819999A (en) * 1953-11-13 1958-01-14 Novo Terapeutisk Labor As Process for crystallization of insulin using freeze dried insulin as seeding material
US2799622A (en) * 1953-11-14 1957-07-16 Novo Terapeutisk Labor As Process of producing insulin crystals of substantially uniform size and compositions thereof

Also Published As

Publication number Publication date
US2920014A (en) 1960-01-05
DK78069C (da) 1954-09-06
GB733740A (en) 1955-07-20
DE962637C (de) 1957-04-25
FR1167005A (fr) 1958-11-19

Similar Documents

Publication Publication Date Title
CY161A (en) Improvements in or relating to a process for the production of crystalline insulin
CY170A (en) Improvements in or relating to the production of insulin crystals
MY5700028A (en) Improvements in or relating to a process for the production of crystalline insulin
CY160A (en) Improved process for the production of crystalline insulin
AU161838B2 (en) A process of production of insulin in crystalline form
AU1407952A (en) A process of production of insulin in crystalline form
GB750611A (en) Improvements in or relating to a process and machine for the production of bags and the like
GB749735A (en) Improvements in or relating to machines for the production of corrugated paper
MY5700027A (en) Improved process for the production of crystalline insulin
AU154369B2 (en) Improvements in or relating to process of crystallization
AU167681B2 (en) Improvements relating to the production of crystalline ceramic articles
AU216917B2 (en) Improvements in or relating to process for producing a needlelike coke
CA531557A (en) Process of production of crystalline insulin
CA532175A (en) Process of production of crystalline insulin
AU878652A (en) Improvements in or relating to process of crystallization
AU161775B2 (en) A process forthe production of crystalline insulin
AU2535154A (en) Improvements relating to the production of crystalline ceramic articles
AU208013B2 (en) Improvements in or relating to process of preparing carbonaceous material
AU2151956A (en) Improvements in or relating to process for producing a needlelike coke
CA530831A (en) Process for the production of 1:4-dicyano-butene
AU228394B2 (en) Process forthe production of epsilon-halocaproic acids
CA521838A (en) Process for producing alpha-mercapto-carboxylic acids
AU206188B2 (en) Process for the production of new chloro-methylene-tetrahydroindanes
AU159927B2 (en) Process of production of crystalline insulin
AU201477B2 (en) Improvements in or relating to the production of electrolytically treated interlocking members for a slide fastener